Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Panacea Biotec secures $8.205 million contract from UNICEF for polio vaccine supply for 2028.

Aug 05, 2026•4 days ago

Contract Type

contract

ManufacturingBiotechnologyPharmaceutical

Description

Panacea Biotec Limited has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine valued at approximately $8.205 million. This contract is part of a long-term agreement aimed at combating polio, with delivery scheduled for the 2028 calendar year.

Company Information

Company

Panacea Biotec

About

Panacea Biotec is a pharmaceutical company that focuses on research, development, manufacturing, and marketing of pharmaceutical formulations.

Predictive Intelligence
Strategic

ML-powered predictions for Panacea Biotec's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.